亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Identification of C3 complement molecule at the site of injury to blood vessels in the retina of oxygen exposed newborn mice

總結
John T. Flynn, M.D.
技術優勢
This is an alternative treatment for ROP. Current treatments are invasive surgeries on the eye, with no information on the long-term effects. Patent information:Patent Pending (WO/2012/118833)
技術應用
Method for treating, preventing, or reducing oxygen damage in ROPNew Information regarding the underlying cause of ROP will lead to:Better treatment protocols at Neonatal Intensive Care Units (NICUs) to prevent ROPIdentification of additional risk factor(s)Development of drug therapy
詳細技術說明
John T. Flynn, M.D.
*Abstract
None
*Inquiry
Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
2703
*Principal Investigation
*Publications
M.F. Chiang, R. Gelman, M.E. Martinez-Perez, Y.E. Du, D.S.Casper, L.M. Currie, P.D. Shah, J. Starren, J.T. Flynn. Image analysis for retinopathy of prematurity diagnosis. Journal of American Association for Pediatric Opthalmology and Strabismus, Vol 13, Issue 5, Oct. 2009, pp. 438-445.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備